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Introduction
Protein tyrosine phosphatase 1B (PTP1B) is targeted to the
cytosolic face of the membranes of the endoplasmic reticulum
(ER) via a hydrophobic sequence at its C terminus (Frangioni
et al., 1992). As the catalytic domain faces the cytosol, ER
bound enzyme has the potential for substrate
dephosphorylation throughout the extensive branching
network occupied by the ER. Indeed, recent biochemical, as
well as FRET (fluorescence resonance energy transfer) and
BRET (bioluminescence resonance energy transfer) analyses
show that PTP1B at the ER interacts directly with, and
dephosphorylates, several cell surface receptors, either during
their biosynthetic route to the cell surface, or after being
endocytosed (Haj et al., 2002; Boute et al., 2003; Romsicki et
al., 2004; Cohen et al., 2004). PTP1B can be cleaved by
calpains at a site upstream from the ER targeting sequence,
producing a cytosolic ~42 kDa form (Frangioni et al., 1993).
Such a cleaved form of PTP1B has been shown to associate
with N-cadherin (Balsamo et al., 1998) and to depend on
phosphorylation of PTP1B Y152 (Rhee et al., 2001) catalyzed
by the tyrosine kinase Fer (Xu et al., 2004). In contrast to the
association of this cleaved and presumably diffusible form with
cadherin, full length PTP1B is associated with the 1-integrin
complex of cytosolic proteins (Arregui et al., 1998). PTP1B
has also been shown to interact directly with the adaptor
protein p130Cas (Liu et al., 1996), which is localized at focal
adhesions (Harte et al., 1996). The interaction between PTP1B
and p130Cas is mediated by a proline-rich motif in PTP1B that
interacts with the Src homology 3 (SH3) domain of p130Cas
(Liu et al., 1996). Mutation of the proline-rich motif impairs
many of the integrin-dependent effects regulated by PTP1B
(Liu et al., 1998; Dadke and Chernoff, 2002). Thus, the
proline-rich motif of PTP1B may be involved in the association
of PTP1B with cell-matrix adhesions.
Cell-matrix adhesion sites are heterogeneous in
composition, shape and behavior (Zamir et al., 2000; Zamir
and Geiger, 2001; Yamada et al., 2003; Webb et al., 2003).
Small dot-like adhesions near the edges of lamellar extensions
are known as focal complexes. Larger, elongated adhesions
associated with actin stress fibers that can be induced by rho-
dependent, acto-myosin contractility, are named focal
adhesions. Quantitative studies show that most focal
complexes are rich in paxillin and poor in zyxin, -actinin and
tensin; these latter proteins incorporate into focal complexes
later during their maturation into focal adhesions (Laukaitis et
al., 2001; Zaidel-Bar et al., 2003). The molecular mechanisms
involved in the assembly and maturation of cell-matrix sites are
largely unknown, but depend to some degree on the combined
activity of protein tyrosine kinases and phosphatases
(Miyamoto et al., 1995; Volberg et al., 2001; Larsen et al.,
2003). The tyrosine phosphatase SHP2 was recently shown to
be necessary for the incorporation of -actinin into focal
complexes and for their maturation to focal adhesions (von
Wichert et al., 2003).
Turnover of cell-matrix sites and cell motility are also
regulated by phosphorylation/dephosphorylation events. Cells
derived from mice null for the tyrosine kinases FAK and Src
display reduced cell-matrix turnover and cell motility (Ilic et
al., 1995; Klinghoffer et al., 1999; Webb et al., 2004). Cells
derived from mice that are null for PTP1B also display defects
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in cell spreading (Cheng et al., 2001). Furthermore, L-cells
expressing a dominant negative form of PTP1B have low Src
activity and small cell-matrix sites, and are similarly impaired
in cell spreading (Arregui et al., 1998). These observations are
consistent with the hypothesis that PTP1B is instrumental in
activation of Src through dephosphorylation of the C-terminal
tyrosine (Arregui et al., 1998; Bjorge et al., 2000; Cheng et al.,
2001; Dadke and Chernoff, 2003). PTP1B also activates
integrin-signaling pathways and motility by controlling the
level of phosphorylation of additional substrates such as CrkII
(Takino et al., 2003).
In the present study we examined the role of the proline-rich
motif, the insulin and cadherin-binding motif, and the ER
targeting sequence in localization of PTP1B to cell-matrix
adhesion sites. For these studies we used the substrate-trapping
mutant of PTP1B in which the invariant aspartate residue at
position 181 is replaced by alanine. This substrate trapping
mutant binds to its substrates with similar affinity as the wild-
type enzyme, but catalytic activity is significantly reduced
(Flint et al., 1997). The resulting enzyme-substrate complexes
have been shown to be stable enough to be visualized by optical
techniques (Haj et al., 2002; Boute et al., 2003; Romsicki et
al., 2004). We find that PTP1B is positioned at the distal tips
of cell-matrix adhesion sites through dynamic extensions of the
ER. We also show that PTP1B is preferentially localized to
paxillin-rich foci, and that maturation of these foci and lamellar
extension is impaired in PTP1B null cells, supporting a role of
PTP1B in the maturation and stabilization of focal adhesions.
Results
PTP1B localizes to the distal tip of cell-matrix adhesion
sites
We previously found that PTP1B is associated with the 1-
integrin complex of proteins and that it affects cell-matrix
adhesion and signaling (Arregui et al., 1998; Pathre et al.,
2001). Thus, PTP1B probably acts on substrates located in cell
matrix sites, modifying their activity (Arregui et al., 1998;
Bjorge et al., 2000; Cheng et al., 2001; Takino et al., 2003). To
identify potential PTP1B substrates at cell-matrix adhesion
sites we used the substrate-trapping mutant PTP1B D181A
(PTP1B DA) which forms long-lived complexes with
substrates. This substrate-trapping mutant has proved to be
crucial for detection, by FRET and BRET, of complexes
formed between PTP1B and different growth factor receptors
at the surface of the ER (Haj et al., 2002; Boute et al., 2003;
Romsicki et al., 2004). Mouse fibroblasts derived from mice
null for PTP1B (Klaman et al., 2000) were transiently
transfected with GFP fusions of the wild-type PTP1B and
PTP1B DA. Whereas GFP-wild-type PTP1B has the typical
ER distribution (Fig. 1A) (Frangioni et al., 1992; Arregui et al.,
1998), equivalent levels of GFP-PTP1B DA also localized to
small punctate structures near cell margins (Fig. 1B, also see
inset). These puncta are also apparent using anti-PTP1B
antibody staining of PTP1B null cells stably reconstituted with
PTP1B DA not fused to GFP (Haj et al., 2002) (Fig. 1C)
indicating that GFP has no effect on the distribution of PTP1B.
The fact that punctate structures were apparent only with
PTP1B DA, at equivalent expression levels as the wild-type
form (Fig. 1A,B,D) indicates that stabilization of enzyme-
substrate complexes is necessary for their visualization. In
concert with this, prior treatment of the cells with pervanadate,
which inhibits PTPs by binding to and modifying the essential
catalytic cysteinyl residues at their active sites (Huyer et al.,
1997), leads to the disappearance of the punctate structures at
the cell-matrix adhesion foci (not shown).
We next examined the co-localization of the PTP1B DA with
several structural proteins commonly used as markers of cell-
matrix adhesion complexes. Confocal sections taken at the cell-
matrix interface revealed that PTP1B DA localizes at the distal
tips of foci stained with vinculin, paxillin (Fig. 2A,B), and
zyxin (not shown). The PTP1B DA puncta also localize at the
tips of actin stress fibers (Fig. 2C) and microtubules (Fig. 2D)
consistent with the fact that cell-matrix adhesion complexes are
sites of anchorage to the actin cytoskeleton and the termination
of microtubules (Calderwood et al., 2000; DeMali and
Burridge, 2003; Small and Kaverina, 2003; Ezratty et al.,
Journal of Cell Science 119 (7)
Fig. 1. The substrate-trapping PTP1B DA localizes to punctate structures at cell margins. Cells were plated on fibronectin-coated coverslips,
fixed and examined by wide-field fluorescence microscopy. (A) PTP1B null cells were transfected with GFP-wild-type PTP1B or (B) GFP-
PTP1B DA and visualized 20 hours later. The arrows indicate punctate structures (B, inset). Note the absence of punctate structures in A.
(C) PTP1B null cells stably reconstituted with PTP1B DA were stained with monoclonal anti-PTP1B followed by Alexa Fluor 488-conjugated
secondary antibody. Note that the punctate structures look larger because of the signal amplification by the antibodies. Bar, 20 m.
(D) Representative western blot of equivalent amounts of soluble protein prepared from PTP1B null cells (lane 1); PTP1B null cells transiently
transfected with GFP-wild type PTP1B (lane 2); GFP-PTP1B DA (lane 3); or stably reconstituted with PTP1B DA (lane 4). The endogenous
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2005). We also assessed the localization of two additional
substrate-trapping mutants of PTP1B: PTP1B C215S (PTP1B
CS), in which the essential cysteine of the active site is replaced
by a serine, localized to the ER and no clear punctate structures
were seen over cell-matrix foci (not shown); the double mutant
PTP1B DA plus Q262A (PTP1B DA/QA), in which the
invariant Gln262 involved in the hydrolysis of the cysteinyl
phosphate intermediate has been replaced by alanine, displayed
a punctate distribution at the distal tips of cell-matrix foci
similar to PTP1B DA (Fig. 2E). These results are consistent
with previous reports showing that PTP1B CS is a weak
substrate-trapping mutant compared to PTP1B DA and PTP1B
DA/QA (Flint et al., 1997; Xie et al., 2002). Again, these data
indicate that the stability of the enzyme-substrate complexes is
a key feature allowing for visualization of PTP1B at cell-matrix
sites.
Cell-matrix adhesion complexes are sites of intense tyrosine
phosphorylation/dephosphorylation and sources of signaling
complexes that regulate cell behavior, including the turnover
of cell-matrix adhesion sites (Giancotti and Ruoslahti, 1999;
Webb et al., 2002). Two major tyrosine kinases, FAK and Src,
localize to cell-matrix adhesion sites and are responsible for
the bulk of tyrosine phosphorylation at these sites (Gilmore and
Romer, 1996; Klinghoffer et al., 1999). Several laboratories
including ours have demonstrated that Src is activated by
PTP1B (Arregui et al., 1998; Bjorge et al., 2000; Cheng et al.,
2001; Dadke and Chernoff, 2003). We found that the PTP1B
DA puncta do co-localize tightly with Src (Fig. 3A-F) and a
subpopulation of the PTP1B DA puncta co-localize with the
phospho-active form of Src in lamellae (Fig. 3G). Furthermore,
Src and PTP1B co-immunoprecipitate (Fig. 3H) (Liang et al.,
2005). These data suggest that the co-localization of PTP1B
with Src is probably due to the binding of PTPB DA to the C-
terminal regulatory tyrosine of Src (Bjorge et al., 2000; Cheng
et al., 2001).
PTP1B puncta also co-localize tightly with FAK (Fig. 4A-
C). Dual confocal time-lapse analysis revealed that puncta
containing FAK/PTP1B DA are dynamic, giving the
appearance of fusing with each other or splitting, and some
disappear from the plane of the cell-substrate interface (Fig.
Fig. 2. PTP1B DA puncta co-
localize with proteins associated
with cell-matrix adhesion sites and
the cytoskeleton. PTP1B null cells
stably expressing PTP1B DA (A,B)
or PTP1B null cells transiently
transfected with GFP-PTP1B DA
(C,D), or GFP-PTP1B DA/QA (E)
were plated on fibronectin-coated
coverslips and examined 24 hours
later. (A) Cells double-stained with a
polyclonal anti-PTP1B and a
monoclonal (hVIN-1) anti-vinculin
followed by secondary antibodies
conjugated with Alexa Fluor 488 and
Alexa Fluor 568, respectively. Shown is one confocal section (0.5 m) at the cell-matrix interface. (B) Cells stained with anti-PTP1B and anti-
paxillin followed by secondary antibodies conjugated with Alexa Fluor 568 and Alexa Fluor 488, respectively. (C) Cells stained with
rhodamine-phalloidin. Dotted line indicates the boundary of the cell. (D) Cells stained with anti-tubulin (DM1 A), followed by a secondary
antibody conjugated with Alexa Fluor 568. (E) Cells stained with anti-PTP1B followed by a secondary antibody conjugated with Alexa Fluor
568. In all cases, arrows indicate punctate structures. Note that punctate structures localize at the distal tips of vinculin and paxillin (A,B,E), as
well as at the tips of actin (C) and microtubules (D). Bars, (A,B,E) 20 m; (C,D) 10 m.
Fig. 3. PTP1B puncta co-localize with Src and Src-pY418 at cell
margins. PTP1B null cells were transfected with GFP-PTP1B DA and
examined 20 hours later by fluorescence microscopy (A-G). Cells
were labeled with anti-Src (A-F) or anti-Src-pY418 (G) followed by a
secondary antibody conjugated with Alexa Fluor 568. Note the co-
localization (yellow) at large punctate structures formed at the
peripheral ER network (C), or in small punctate structures at
individual ER tubules at the cell margins (F) Arrows indicate puncta.
Note that a subpopulation of PTP1B DA puncta is coincident with the
phospho-active form of Src (G). Bars, (A-C) 10 m; (D-G) 15 m.
(H) The formation of Src-PTP1B complexes was analyzed by
immunoprecipitation. PTP1B null cells (–/–), and cells stably
expressing PTP1B wild type (Wt) or PTP1B DA (DA) were lysed and
immunoprecipitated with anti-PTP1B. The amount of PTP1B and Src
in the lysate (input) and in the immunoprecipitates was detected with












4D). These observations indicate that FAK and PTP1B DA
may also be present in the same complex of proteins.
Dynamic projections of ER tubules at the cell margins
position full length PTP1B DA near the distal tip of cell-
matrix adhesion sites
We compared the co-localization of PTP1B DA with markers
of the endosomal compartment and the ER. Markers for
distinct endocytic pathways, including Rab5, Rab7, dynamin
K44A and caveolin 1 (Pfeffer, 2001; Pelkmans and Helenius,
2002) did not co-localize with PTP1B DA (Fig. 5A-D).
However, PTP1B DA puncta co-localized with the ER marker
calnexin (Fig. 5E-G). These data suggest that the positioning
of PTP1B may be dependent on extension of the ER to the cell
margins, a process dependent on microtubules, as
demonstrated by retraction of the peripheral ER network on
treatment of cells with the microtubule depolymerizing drug
nocodazole (Terasaki et al., 1986; Waterman-Storer and
Salmon, 1998). Indeed, we find that the puncta do not develop
if nocodazole (0.5 M) is added prior to the expression of
transfected GFP-PTP1B DA in PTP1B null cells (Fig. 5I,
compare with 5H). Furthermore, puncta disappeared when
nocodazole (5 M) is added after 24 hours of GFP-PTP1B DA
transfection, with a halftime of ~1 hour (not shown).
In an attempt to visualize the formation and dynamics of the
PTP1B DA puncta we analyzed, using time-lapse videos, the
co-distribution of GFP-PTP1B DA and mRFP-paxillin after
transfection into PTP1B null cells. Time-lapse series were
started 30 minutes post-plating on fibronectin to facilitate the
visualization of cells during active spreading. Most paxillin
foci were at the extending cell margins and appeared to be
accompanied by fast projections of ER tubules containing
GFP-PTP1B DA (Fig. 6; Movie 1 in supplementary material).
These tubules elongated and retracted along the long axis of
the paxillin foci and formed transient puncta at their tips as
already noted (Fig. 6A-C, arrows; see also Movie 1 in
supplementary material). With time the puncta increased in
size as new adjacent ER tubules fuse with the pioneer ones
(Fig. 6A, 120-154 minutes; C, 114 minutes; see also Movie 1
in supplementary material). These observations suggest that
GFP-PTP1B DA puncta form with the assembly of paxillin-
containing foci in association with tubular extensions of the
ER; however, the puncta are dynamic and can disappear
independently of the turnover of the foci (Fig. 6B, 14-46
minutes, yellow arrows).
ER targeting sequences are required for localization of
PTP1B at the distal tip of cell-matrix adhesion complexes
PTP1B interacts with its partners through distinct targeting
sequences. A conserved proline-rich motif downstream from
the catalytic domain mediates interactions with several SH3
domain-containing proteins. Substitution of two critical proline
Journal of Cell Science 119 (7)
Fig. 4. PTP1B puncta co-localize with FAK in fixed and living cells. (A-C) PTP1B null cells stably expressing PTP1B DA double labeled with
anti- FAK and anti-PTP1B, followed by secondary antibodies conjugated with Alexa Fluor 568 (A) and Alexa Fluor 488 (B), respectively. Note
the high overlap of both proteins at the cell margins (arrows). (D) PTP1B null cells co-transfected with mRFP-PTP1B DA and GFP-FAK
analyzed by time-lapse confocal microscopy after 24 hours. Note that most PTP1B DA puncta also contain FAK (in yellow), however, in
instances of non co-localization, FAK has an elongated distribution. Arrows indicate puncta containing both PTP1B DA and FAK that move or











1237PTP1B in cell-matrix adhesion sites
residues (Pro309/310) with alanine abrogates the in vivo
interaction of PTP1B with the SH3 domain of p130Cas (Liu et
al., 1996). We replaced these two proline residues with alanine
in PTP1B DA (PTP1B-DA/PA) and fused this construct to
GFP. PTP1B DA/PA retained its localization to the ER and
formed peripheral punctate structures identical to those seen
with GFP-PTP1B DA. Importantly, the co-localization of
PTP1B-DA/PA with cell-matrix markers (and actin, not shown)
was not affected by disruption of the SH3 binding motif (Fig.
7A,B). These observations indicate that the proline-rich SH3-
binding motif is not essential for the targeting of PTP1B to cell-
matrix sites.
It was previously shown that PTP1B tyrosine residues 152
and 153 are required for the direct interaction with the insulin
receptor (Dadke et al., 2000) and that phosphorylation of one
of these tyrosine residues (152) is essential for interaction with
N-cadherin (Rhee et al., 2001). We replaced these two tyrosine
residues with phenylalanine (PTP1B DA/YF) and tested the
resultant construct for its localization to cell-matrix adhesion
Fig. 5. PTP1B DA puncta do not co-localize with endocytic markers,
but do co-localize with ER markers and require intact microtubules.
PTP1B null cells stably expressing PTP1B DA were transfected with
different endocytic markers: (A) the dominant-negative mutant GFP-
dynamin K44A; (B) GFP-Rab 5; (C) GFP-Rab 7; (D) GFP-caveolin
1. Cells were fixed and stained with anti-PTP1B followed by a
secondary antibody conjugated with Alexa Fluor 568. (E-G) PTP1B
null cells were transfected with GFP-PTP1B DA (E) and stained with
anti-calnexin antibody (F) followed by a secondary antibody
conjugated with Alexa Fluor 568. The merged image is shown in G.
PTP1B null cells were transfected with GFP-PTP1B DA in the
absence (H) or presence (I) of Nocodazole (0.5 M). After 20 hours,
cells were fixed and stained with rhodamine-phalloidin. Note that the
punctate structures (arrows in H) are not longer visible in the
presence of nocodazole (I). Bars, (A-G) 20 m; (H,I) 25 m.
Fig. 6. PTP1B DA puncta
develop from ER tubules
extending over cell-matrix
adhesion foci. PTP1B null cells
were co-transfected with GFP-
PTP1B DA and mRFP-paxillin,
and 24 hours later were replated
for 30 minutes on fibronectin-
coated coverslips. Cells were
immediately analyzed by time-
lapse confocal microscopy.
Different regions of a cell in
selected frames of a time-lapse
sequence are shown (A-C).
Numbers over the time-lapse
series indicate minutes elapsed.
Arrows indicate punctate
structures that develop from ER
tubules at the tips of new
paxillin foci. Yellow arrows in B
indicate a punctate structure that
forms and disappears, whereas
the paxillin foci remain. Note
that the punctate structures
become larger after the arrival of
additional ER tubules
(arrowheads, 120 minutes in A;
26 minutes in B; 114 minutes in
C). Bar, 10 m. See also Movie












sites. PTP1B DA/YF targeted correctly to the ER and also
formed puncta that were indistinguishable from PTP1B DA
(Fig. 7C,D).
The bulk of PTP1B is associated with the cytosolic face of
the ER through a hydrophobic C-terminal sequence (Frangioni
et al., 1992) which may be cleaved by calpain activation
(Frangioni et al., 1993; Tonks, 2003). To examine the
contribution of this carboxyl-terminal ER targeting sequence
in the localization of PTP1B to cell-matrix adhesion sites, we
prepared two deletion constructs; one that terminated at
glutamic acid 381, removing just the ER targeting sequence
(PTP1B DA/t381), and a larger deletion that terminated at
phenylalanine 280, which also removes the SH3 binding motif
(PTP1B DA/t280). When expressed in cells derived from
PTP1B null mice, both constructs show diffuse fluorescence,
consistent with cytosolic localization. Examination of lamellar
extensions, however, revealed a clear localization of both
constructs at cell-matrix adhesion sites (Fig. 7E,F; only PTP1B
DA/t280 shown). However, in contrast to the ER-anchored
enzyme, both truncated forms distributed throughout the entire
focal adhesion complex (Fig. 7E,F). Similar truncations of non
substrate-trapping PTP1B showed the diffuse distribution but
lacked the accumulation at cell-matrix sites (not shown),
consistent with the prior result indicating that the substrate
trapping form of the enzyme is essential for visualization at
focal adhesions. These results indicate that the ER-targeting
sequence is not essential for gross localization at cell-matrix
adhesion sites, but that it is required to achieve the restricted
distribution at the distal tips of the focal adhesions.
PTP1B associates with newly forming, paxillin-rich focal
complexes
Cell-matrix adhesion sites differ in their molecular
assemblages (Geiger and Bershadsky, 2001; Webb et al.,
2003). Focal complexes are newly forming small adhesions
near the cell margins and are rich in paxillin and poor in zyxin,
whereas mature focal adhesions are larger and ovoid adhesions
that contain a more complex set of proteins including zyxin
(Laukaitis et al., 2001; Zaidel-Bar et al., 2003). To determine
whether PTP1B DA/t280 associates preferentially with one or
another stage of adhesion complex formation, we performed
quantitative and dual time-lapse analysis of the GFP-PTP1B
DA/t280 with either mRFP-paxillin or DsRed-zyxin. We used
the cytosolic, non-ER-targeted form of PTP1B for this analysis
because its distribution in adhesion complexes is less restricted
and thus more easily visualized, and because it remains
associated with cell-matrix sites for longer periods of time;
both factors facilitating the dual time-lapse imaging. In
lamellar extensions, approximately 93% of PTP1B DA/t280
foci were found to contain paxillin (Fig. 8A, and histogram in
B, bar 2) and only 35% also contained zyxin (Fig. 8A, and
histogram in B, bar 1). Most paxillin-containing foci at
lamellae also contained PTP1B DA/t280 (Fig. 8B, bar 3). We
that the distribution and fluorescence intensity of PTP1B
DA/t280 (and PTP1B DA/t381, not shown) match tightly with
that of paxillin over time, as seen by the relatively invariant
yellow color in small growing foci at spreading lamella (Fig.
8C, arrows), as well as in elongated foci in more stationary
regions of the cell. Furthermore, cell-matrix sites in the process
of disassembly in retracting regions of the cell preserved the
relative intensities of PTP1B-DA/t280 and paxillin
fluorescence, suggesting a coordinated dynamic behavior for
both proteins (Fig. 8C, arrowheads). By contrast, the relative
fluorescence intensities of PTP1B-DA/t280 and zyxin, or
paxillin and zyxin, vary according to the region of the cell.
Stationary or extending regions of the cell contained foci with
a predominance of PTP1B DA/t280 and paxillin fluorescence
(more green, Fig. 8D,E, arrows), whereas foci in retracting
regions incorporated zyxin (turning from green or yellow to
red) before disassembly (Fig. 8D,E, arrowheads).
PTP1B expression is required for stabilizing cell-matrix
adhesion sites at spreading lamellae
Our time-lapse experiments show that PTP1B DA puncta
appear and grow at the tips of forming cell-matrix adhesion
sites. The preferential association of PTP1B DA and PTP1B
DA/t280 with paxillin foci as compared to zyxin foci suggests
that PTP1B activity may contribute to formation and/or
stabilization of cell-matrix adhesion sites and thus promote
spreading. Consistent with this view, cells derived from the
PTP1B null mice spread poorly (Cheng et al., 2001) (our
unpublished observations) and L-cells transfected with a
Journal of Cell Science 119 (7)
Fig. 7. PTP1B structural requirements for formation of cell-matrix
adhesion site puncta. PTP1B null cells were transfected with GFP-
PTP1B DA/PA (A,B), GFP-PTP1B DA/YF (C,D) and GFP-PTP1B
DA/t280 (E,F) and fixed 20 hours later. Cells stained with anti-FAK
(A,C) or anti-vinculin (B,D,F), followed by secondary antibodies
conjugated with Alexa Fluor 568. Note that PTP1B DA/PA and
PTP1B DA/YF form typical punctate structures (A-D, arrows)
whereas PTP1B DA/t280 has lost the punctate distribution and
appears throughout the entire area of the cell-matrix adhesion foci
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dominant negative form of PTP1B also show less spreading
than control cells (Arregui et al., 1998). To directly visualize
this phenomena in living cells, and to determine if the
spreading defect is due to the inability to produce lamellar
extensions or to their stabilization, we compared the formation
and stabilization of cell-matrix adhesion sites and lamellar
extensions among PTP1B null cells and cells reconstituted
with wild-type PTP1B after transfection with GFP-labeled
vinculin and GFP-paxillin. Both cell lines were able to extend
lamellae; however, cells reconstituted with wild-type PTP1B
quickly stabilized adhesions by forming small cell-matrix sites
(Fig. 9, wt). By contrast, lamellar extensions formed by the
PTP1B null cells sometimes formed adhesion sites, but these
quickly disappeared along with the retraction of the lamella
(Fig. 9, null). To examine if the small cell-matrix sites in the
PTP1B null cells are defective in incorporating zyxin, a
marker of more mature focal adhesions (Laukaitis et al., 2001;
Zaidel-Bar et al., 2003), we determined the percentage of
paxillin-containing foci that also contained zyxin in the
PTP1B null cells and the cells reconstituted with the wild-type
PTP1B. Interestingly, we found that PTP1B null cells
exhibited a 30% reduction in paxillin-containing foci that also
contained zyxin (Fig. 9, histogram). These observations
indicate that PTP1B null cells are defective in lamellar
stabilization.
Discussion
PTP1B is possibly the most ubiquitous tyrosine phosphatase
and as such has been implicated in many distinct cellular
processes that require precise targeting to potential cellular
substrates. Consistent with this, several distinct targeting
motifs have been identified in addition to the substrate
recognition motif. Here, we provide new insight into the
targeting and role of PTP1B at cell-matrix adhesion sites.
Fig. 8. PTP1B DA/t280 co-localizes preferentially with paxillin-containing foci in lamellae. PTP1B null cells were co-transfected with GFP-
PTP1B DA/t281 and mRFP-paxillin, GFP-PTP1B DA/t280 and DsRed-zyxin, or GFP-paxillin and DsRed-zyxin. 20 hours post-transfection
cells were fixed and analyzed by fluorescence microscopy (A,B), or replated on fibronectin-coated coverslips and analyzed by time-lapse
fluorescence confocal microscopy 24 hours later (C-E). Numbers over the frames indicate the time elapsed. Note that most PTP1B DA/t280
foci in lamellar extensions contain paxillin but not zyxin (A, arrows). Approximately 93% of PTP1B DA/t280 foci contain paxillin (B, bar 2)
and about 35% also contain zyxin (B, bar 1). Most paxillin foci also contain PTP1B DA/t280 (B, bar 3). Results shown are the mean ± s.d. of
three independent experiments (n=30). Time-lapse analysis reveals that the ratio of fluorescence intensities for GFP-PTP1B DA/t280 and
mRFP-paxillin (indicated by the yellow color) does not change significantly over time. New foci at extending lamellae (C, arrows), and foci that
disassemble at retracting regions of the cell (C, arrowheads) maintain constant relative fluorescence intensities of PTP1B and paxillin. In
contrast to paxillin, zyxin and PTP1B DA/t280 do not consistently overlap (D, arrows). New PTP1B DA/t280-rich foci are usually devoid of
zyxin (D, arrows). Foci at retracting sites frequently incorporate zyxin before disassembling (revealed by a change of color from green or
yellow to red, arrowheads). Co-localization of paxillin and zyxin is partial (E). Foci at extending parts of the cell are rich in paxillin foci












The subcellular targeting of PTP1B
PTP1B associates with the ER through a C-terminal
hydrophobic sequence with the catalytic domain facing the
cytosol (Frangioni et al., 1992). A cytosolic species of PTP1B
may also result from removal of the hydrophobic sequence by
calcium-activated proteases of the calpain family (Frangioni et
al., 1993). PTP1B has been shown to dephosphorylate several
cell surface receptor tyrosine kinases, including the insulin
receptor (IR), epidermal growth factor receptor (EGFR) and
platelet-derived growth factor receptor (PDGFR) (Tonks,
2003). Recent work also indicates that a cleaved form of
PTP1B associates with N-cadherin (Balsamo et al., 1998) and
that the full-length form interacts with integrin complexes
(Arregui et al., 1998). In both of these latter cases PTP1B
dephosphorylates components of these adhesion complexes
with significant consequences for their adhesive, as well as
signaling, function (Arregui et al., 2000; Lilien et al., 2002;
Larsen et al., 2003; Lilien and Balsamo, 2005).
What is the cellular compartment in which PTP1B interacts
with and dephosphorylates its substrates has been a recurrent
question. Recent BRET and FRET studies showed that the
substrate-trapping mutant PTP1B D181A (PTP1B DA)
interacts with endocytosed IR, EGFR and PDGFR (Haj et al.,
2002; Boute et al., 2003; Romsicki et al., 2004), although at
least for the IR and the erythropoietin receptor, the evidence
also points to an association with the PTP1B DA during their
biosynthetic pathway (Boute et al., 2003; Cohen et al., 2004).
In the current study we showed that the substrate trapping
PTP1B DA labeled with GFP (GFP-PTP1B DA) is easily
visualized in the ER and at cell-matrix adhesion sites using
fluorescence microscopy. Wild-type GFP-PTP1B appears
largely associated with the ER, however, the substrate-trapping
mutant PTP1B DA appears in punctate structures at the distal
tips of cell-matrix sites, presumably reflecting the trapping of
substrates at these sites. These punctate structures do not
contain Rab5, Rab7, dynamin K44A or caveolin 1, indicating
that they are not part of an endocytic compartment; they do co-
localize with calnexin, an integral ER membrane chaperone
(Schrag et al., 2003). Dual-color time-lapse microscopy also
revealed that the formation of these punctate structures is
associated with ER tubules that project over cell-matrix sites.
Consistent with these observations we found that two deletion
Journal of Cell Science 119 (7)
Fig. 9. Lamellar extensions in cells lacking PTP1B are unstable and contain immature cell-matrix sites. PTP1B null cells (null) and cells
reconstituted with wild-type PTP1B (+wt) were transfected with GFP-vinculin or GFP-paxillin and analyzed by time-lapse confocal
microscopy. Note that PTP1B null cells produce lamellar extensions and assemble vinculin and paxillin foci (arrows); however, the lamellae
quickly retract (arrowheads). By contrast, cells expressing wild-type PTP1B extend lamellae and assemble vinculin and paxillin foci that are
persistent in time (arrows). Bar: 30 m. The percentage of paxillin foci that also contain zyxin in PTP1B null cells and cells stably expressing
wild-type PTP1B is shown in the histogram in the bottom, right panel. Results shown are the mean ± s.d. of three independent experiments
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constructs that lack the ER targeting sequence, PTP1B
DA/t281 and PTP1B DA/t381, distribute diffusely in the
cytosol and in the entire area of adhesion sites, a distribution
easily distinguished from the specific localization of PTP1B
DA at the distal tip of cell-matrix adhesion sites. Our results
suggest that the intrinsic dynamics of the ER positions PTP1B
at the distal tips of adhesion sites. This idea is further supported
by two additional observations: (1) treatment with nocodazole
abolishes the formation of the punctate structures at the
peripheral cell-matrix sites, consistent with the role of
microtubules in extension of the ER (Terasaki et al., 1986;
Waterman-Storer and Salmon, 1998); and (2) the direct
visualization of the genesis of the punctate structures over cell-
matrix sites as they form during cell spreading. Since the
substrate trapping version of PTP1B is required for
visualization at cell-matrix adhesion sites, we presume that the
enzyme is positioned via interaction with its substrates, also
localized specifically at the distal tips of adhesion sites (see
below).
Analysis of the subcellular distribution of PTP1B DA with
deletions of other known targeting motifs further substantiates
the conclusion that it is the interaction with specific substrates
that is responsible for localization at the distal tips of adhesion
sites. One candidate targeting sequence is the proline-rich
motif in PTP1B which acts as a ligand for the SH3 domain of
p130cas (Liu et al., 1996). It was previously shown that
neutralizing mutations of this motif impair many of the
integrin-dependent effects regulated by PTP1B (Liu et al.,
1998; Dadke and Chernoff, 2002). We find that neutralization
of the proline-rich motif in PTP1B DA, or its deletion (PTP1B
DA/t280), does not prevent localization at cell-matrix sites.
Thus, interaction with SH3 domains is not required for the
incorporation of PTP1B DA at cell-matrix sites. However, we
cannot rule out the possibility that SH3 domain-mediated
interactions contribute to stabilization of PTP1B at cell-matrix
sites.
Potential substrates of PTP1B in cell-matrix sites
The formation of enzyme-substrate complexes at cell-matrix
sites appears to be largely responsible for the localization of
PTP1B at the distal tips of cell-matrix adhesion sites; our data
imply that Src is a primary substrate. We and others have
reported that PTP1B dephosphorylates and activates Src
(Arregui et al., 1998; Liu et al., 1998; Cheng et al., 2001).
Furthermore, it has been shown that in fibroblasts, briefly plated
on fibronectin, Src redistributes from the perinuclear region to
the margins of spreading lamellae and becomes transiently
activated (Kaplan et al., 1995). We found that Src co-localizes
with the PTP1B DA puncta at the margins of lamellar
extensions, and can be isolated in a complex with PTP1B by
immunoprecipitation (Fig. 3), consistent with a recent report
(Liang et al., 2005). A reasonable assumption is that these
puncta and those observed at the distal poles of cell-matrix sites
form as a consequence of the stable interactions of the substrate-
trapping version of PTP1B with Src. Novel methods for
visualizing interactions at the nanometer range, such as
fluorescence resonance energy transfer (Sekar and Periasamy,
2003) and bimolecular fluorescence complementation (Hu and
Kerppola, 2002) would be valuable for testing the direct
interaction between PTP1B and Src in cell-matrix sites. We are
in fact pursuing these studies at this time.
Further reinforcing the idea that Src is a/the prominent
substrate of PTP1B at cell-matrix adhesion sites is the finding
that cells derived from mice null for each of these enzymes
have overlapping defects. Cells derived from mice null for Src
and FAK are defective in spreading (Ilic et al., 1995;
Klinghoffer et al., 1999) suggesting that these proteins play a
key role in the maturation or stabilization of cell-matrix
adhesion sites. This is consistent with our previous data
showing that expression of a dominant-negative PTP1B in L-
cells results in decreased Src activity, and defects in integrin-
mediated adhesion and spreading (Arregui et al., 1998).
Delayed spreading is also seen in cells derived from mice null
for PTP1B (Cheng et al., 2001). Our time-lapse observations
also indicate that, whereas cells derived from mice null for
PTP1B have the capacity to assemble cell-matrix sites, these
sites are less stable and lamellar extensions tend to retract
quickly. Furthermore, the percentage of paxillin foci that also
contain zyxin (as a marker of more complex and mature cell-
matrix adhesion sites) in the PTP1B null cells is consistently
lower than that in the cells reconstituted with the wild-type
PTP1B.
The role of PTP1B at cell-matrix adhesion sites
What would be the consequence of activation of Src by PTP1B
in cell-matrix sites? After integrin stimulation, Src
phosphorylates and forms signaling complexes with FAK
(Hanks et al., 2003; Parsons, 2003; Mitra et al., 2005). By time-
lapse microscopy we found that mRFP-PTP1B DA and GFP-
FAK are constituents of a common dynamic compartment (Fig.
4). One of the roles of PTP1B in cell-matrix sites may be the
activation of the Src-FAK signaling complex (see also Arregui
et al., 1998; Liang et al., 2005), an event that may contribute
to the maturation of cell-matrix sites from paxillin-rich to
zyxin-rich foci. Time-lapse analyses showed that PTP1B
DAt/281 co-localizes preferentially with paxillin-rich foci than
with zyxin-rich foci. Furthermore, the percentage of paxillin
foci that also contain zyxin (as a marker of more complex and
mature cell-matrix adhesion sites) in the PTP1B null cells is
consistently lower than that in the cells reconstituted with the
wild-type PTP1B.
In conclusion, the observations presented here indicate that
PTP1B is localized to the distal tip of newly forming cell-
matrix adhesion sites through the dynamic activity of the ER
and associated microtubules, and that it plays a positive role in
the maturation of new cell-matrix adhesion sites.
Materials and Methods
Antibodies and reagents
Monoclonal antibodies against PTP1B, FAK and paxillin were from BD
Transduction Laboratories (Lexington, KY, USA). The polyclonal anti-PTP1B was
from Upstate Biotechnologies (Lake Placid, NY, USA). The monoclonal anti-
tubulin, anti-human vinculin, and the polyclonal anti-calnexin antibodies were from
Sigma-Aldrich (St Louis, MO, USA). Polyclonal anti-Src was from Santa Cruz
Biotechnology (Santa Cruz, CA, USA) and the polyclonal anti-Src-pY418 was from
Biosource International (Camarillo, CA, USA). Rhodamine-phalloidin and
fluorescent antibodies were from Molecular Probes (Eugene, OR, USA). All other
reagents were from Sigma-Aldrich (St Louis, MO, USA).
Immunoprecipitation and western blots
Mouse fibroblasts derived from mice null for PTP1B were lysed on ice with Tris-
buffered saline (TBS; 20 mM Tris-HCl, pH 7.4, 137 mM NaCl) containing 1%
Triton X-100, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 g/ml leupeptin, 5
g/ml aprotinin, 2.5 mM NaVO3 and 10 mM NaF. The cell lysates were centrifuged












monoclonal anti-PTP1B antibody (3 hours at 4°C), and agarose-conjugated anti-
mouse antibody (1.5 hours). After washing with lysis buffer, the immunocomplexes
were boiled in SDS-PAGE sample buffer. Supernatants were fractionated by SDS-
PAGE and transferred to polyvinyl difluoride membranes. Blots were initially
probed with a polyclonal anti-PTP1B and revealed by enhanced chemiluminescence
(ECL). Then, blots were stripped (30 minutes at 55°C) with TBS containing 5% 2-
mercaptoethanol and 2% SDS, and re-probed with a polyclonal anti-Src antibody.
For the western blot shown in Fig. 1 whole cell extracts were prepared as above
and equivalent amounts of soluble protein (~30 g) were loaded per lane.
Immunofluorescence
Cells grown on fibronectin-coated coverslips (20 g/ml) were fixed with 4%
paraformaldehyde in PBS for 20 minutes, permeabilized with 0.5% Triton X-100
in PBS for 10 minutes, and blocked with 3% BSA in PBS for 60 minutes. After
incubation with primary (overnight at 4°C) and fluorescent-conjugated secondary
antibodies (45 minutes), the cells were mounted in Vectashield (Vector Laboratories,
Burlingame, CA, USA) and analyzed using a Nikon E600 microscope (Melville,
NY, USA)  with a 100/1.3 NA objective coupled to a Spot RT Slider CCD camera
(Diagnostic Instruments, Sterling Heights, MI, USA), or with a Bio-Rad MRC 1024
laser scanning confocal microscope (Hercules, CA, USA) with a 60/1.4 NA
objective. For quantitative analysis in Figs 8 and 9, paired, two-color images were
acquired, adjusting the exposure times to obtain the maximal dynamic range without
saturating the detector. These images were analyzed with the ImageJ software
(Wayne Rasband, NIH, Bethesda, MD, USA) to determine co-localization. The
intensity of the fluorescence signal in the positive scores was at least twice that of
the surrounding area.
DNA constructs
The substrate trapping PTP1B D181A (PTP1B DA) was obtained by PCR using
chick PTP1B (Balsamo et al., 1998) as a template. The PCR product was cloned at
the C terminus of enhanced GFP (pEGFP-C3; Clontech BD Biosciences, Mountain
View, CA, USA) between XhoI and XmaI sites. Three additional point mutants were
performed using the GFP-PTP1B DA as a template: PTP1B DA/PA, in which
prolines 309 and 310 were replaced by alanines; PTP1B DA/YF, in which tyrosines
152 and 153 were replaced by phenylalanines, and PTP1B DA/QA, in which
glutamine 262 was replaced by alanine. We also prepared, by PCR, two C-terminal
deletions of the GFP-PTP1B DA: PTP1B DA/t381 and PTP1B DA/t280, in which
PTP1B was truncated after glutamic acid 381 and after phenylalanine 280,
respectively. These truncations were cloned between XhoI and KpnI sites. All
mutations were confirmed by DNA sequencing. To prepare the PTP1B DA fused to
the C terminus of monomeric red fluorescent protein (mRFP) (Campbell et al.,
2002), the mRFP cDNA (provided by R. Tsien, Howard Hughes Medical Institute,
University of California, San Diego, CA, USA) was amplified by PCR and cloned
into the NheI/XhoI sites of the pEGFP-C3-PTP1B DA plasmid replacing the EGFP
with the mRFP. GFP-paxillin was provided by K. Yamada (National Institute of
Dental and Craniofacial Research, NIH, Bethesda, MD, USA) and GFP-FAK was
provided by D. Webb (Department of Cell Biology, University of Virginia,
Charlottesville, VA, USA). To prepare mRFP-paxillin, the paxillin cDNA was
amplified by PCR and cloned in the XhoI/KpnI sites of the plasmid pmRFP-C1
(provided by Q. Wang and S. Green, Department of Biological Sciences, University
of Iowa, Iowa City, IA, USA), replacing the EGFP with mRFP. GFP-vinculin was
provided by T. Volberg and B. Geiger (Department of Molecular Cell Biology,
Weizmann Institute of Science, Rehovot, Israel). DsRed-zyxin was provided by A.
Huttenlocher (Department of Pediatrics and Pharmacology, University of
Wisconsin, Madison, WI, USA). Plasmids encoding GFP-dynamin K44A, GFP-
Rab5 and GFP-Rab7 were provided by Dr J. Martina (National Institute of Child
Health and Human Development, NIH, Bethesda, MD, USA). Caveolin-1-GFP was
provided by M. Parat (Department of Cell Biology, Cleveland Clinic Foundation,
The Lerner Research Institute, Cleveland, OH, USA).
Cell culture and DNA transfection
The generation of the PTP1B null cell line, and those reconstituted with the wild-
type PTP1B or the substrate trapping PTP1B DA have been previously described
(Klaman et al., 2000; Haj et al., 2002) and were provided by Benjamin Neel
(Department of Medicine, Beth Israel Deaconess Medical Center and Harvard
Medical School, Boston, MA, USA). The control fibroblast cell line used in Fig. 1
was provided by P. Soriano (Fred Hutchinson Research Center, Seattle, WA, USA)
and prepared as described previously (Klinghoffer et al., 1999). All cells were
cultured in high glucose DMEM containing L-glutamine, supplemented with 10%
fetal bovine serum, penicillin and streptomycin (Invitrogen Corp, Carlsbad, CA,
USA). Transient transfections of PTP1B null cells were performed in 24-well tissue-
culture plates using lipofectamine 2000 (Invitrogen Corp, Carlsbad, CA, USA) and
1.5 g (single transfections) or 3 g (equimolar, for double transfections)
DNA/well.
Time-lapse imaging
Twenty hours after transfection, cells were resuspended with trypsin and seeded at
30% confluency on fibronectin-coated coverslips attached to the bottom of 60 mm
dishes. Single-color time-lapse imaging was performed in cells transfected with
GFP-fusion proteins. Dual-color time-lapse imaging was performed in cells co-
transfected with GFP and mRFP- or DsRed-fusion proteins. Imaging medium was
phenol red-free, high-glucose Dulbecco’s modified Eagle’s medium containing 4
mM L-glutamine and 25 mM Hepes buffer (Invitrogen Corp, Carlsbad, CA, USA),
supplemented with 10% fetal bovine serum and antibiotics. The medium was
maintained at 36°C by warm, forced air. Cells were observed using a DMIRE2 Leica
inverted microscope with a 63/1.4 NA oil objective. Confocal images were
acquired every 2 minutes on a Leica SP2 AOBS confocal microscope, at a scanning
rate of 400 Hz and in a 512512 pixel array format. Pinhole size was set at 2 Airy
disks to improve light collection and PMT gain and offset was set so that at the
starting point the highest signal was just below the detector saturation and the
background was slightly above the detection floor. For single-color image
acquisition the 488-nm line of the Argon laser was used, and the 500-600 nm
emission was collected. For dual-color time-lapse analysis, the images were
acquired using the line-interlaced sequential excitation mode, with the 488-nm line
of the Argon laser for GFP (500-535 nm emission collected) and the 543-nm line
of the helium/neon laser for DsRed and mRFP (555-700 nm emission collected).
The lasers were used at minimum power and at 25% transmission. Under our
experimental conditions we did not detect significant photo-bleaching. Image
sequences were built using the ImageJ software (Wayne Rasband, NIH, Bethesda,
MD, USA).
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